Inhibikase Therapeutics' Biz Plan Competition Round

Inhibikase Therapeutics raised a round of funding on April 06, 2009. Investors include Five Ventures Business Plan Competition.

Inhibikase Therapeutics is a class of drug that is simultaneously effective against bacterial and viral infections in humans.…

Articles about Inhibikase Therapeutics' Biz Plan Competition Round: